CNBC Fast Money Halftime Report March 18, 2016
Biotech is down 3 . A lot of this is politics and the unknown there but also these stocks were super, super great performers over the last five, six, or seven years and i still think theyre pretty overowned so i think that you can actually, based on the bull packs, i think you can start to look at some of the bio techs and i do still think you juan to find special situation stories. Either new management teams or companies that have gotten hit really hard from currency so im kind of looking at Something Like an abbott labs. A back administer. At a United Health care im not in a rush to buy the...